Switch to:
Also traded in: Austria, Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.97
CERN's Cash-to-Debt is ranked lower than
74% of the 1972 Companies
in the Global Health Information Services industry.

( Industry Median: 10.48 vs. CERN: 0.97 )
Ranked among companies with meaningful Cash-to-Debt only.
CERN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.5  Med: 1.42 Max: N/A
Current: 0.97
Equity-to-Asset 0.71
CERN's Equity-to-Asset is ranked higher than
69% of the 1868 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. CERN: 0.71 )
Ranked among companies with meaningful Equity-to-Asset only.
CERN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.44  Med: 0.63 Max: 0.79
Current: 0.71
0.44
0.79
Interest Coverage N/A
CERN's Interest Coverage is ranked higher than
72% of the 1623 Companies
in the Global Health Information Services industry.

( Industry Median: 138.33 vs. CERN: N/A )
Ranked among companies with meaningful Interest Coverage only.
CERN' s Interest Coverage Range Over the Past 10 Years
Min: 17.1  Med: 76.09 Max: N/A
Current: N/A
Piotroski F-Score: 8
Altman Z-Score: 10.23
Beneish M-Score: -2.82
WACC vs ROIC
7.29%
16.05%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating Margin % 19.10
CERN's Operating Margin % is ranked higher than
85% of the 1918 Companies
in the Global Health Information Services industry.

( Industry Median: 4.78 vs. CERN: 19.10 )
Ranked among companies with meaningful Operating Margin % only.
CERN' s Operating Margin % Range Over the Past 10 Years
Min: 13.43  Med: 19.21 Max: 22.43
Current: 19.1
13.43
22.43
Net Margin % 13.40
CERN's Net Margin % is ranked higher than
81% of the 1918 Companies
in the Global Health Information Services industry.

( Industry Median: 3.36 vs. CERN: 13.40 )
Ranked among companies with meaningful Net Margin % only.
CERN' s Net Margin % Range Over the Past 10 Years
Min: 8.36  Med: 13.05 Max: 15.44
Current: 13.4
8.36
15.44
ROE % 16.25
CERN's ROE % is ranked higher than
76% of the 1858 Companies
in the Global Health Information Services industry.

( Industry Median: 6.34 vs. CERN: 16.25 )
Ranked among companies with meaningful ROE % only.
CERN' s ROE % Range Over the Past 10 Years
Min: 12.37  Med: 14.53 Max: 16.32
Current: 16.25
12.37
16.32
ROA % 11.46
CERN's ROA % is ranked higher than
83% of the 1975 Companies
in the Global Health Information Services industry.

( Industry Median: 2.89 vs. CERN: 11.46 )
Ranked among companies with meaningful ROA % only.
CERN' s ROA % Range Over the Past 10 Years
Min: 7.98  Med: 10.63 Max: 12.18
Current: 11.46
7.98
12.18
ROC (Joel Greenblatt) % 48.27
CERN's ROC (Joel Greenblatt) % is ranked higher than
62% of the 1934 Companies
in the Global Health Information Services industry.

( Industry Median: 22.33 vs. CERN: 48.27 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CERN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 36.87  Med: 48.76 Max: 73.16
Current: 48.27
36.87
73.16
3-Year Revenue Growth Rate 19.10
CERN's 3-Year Revenue Growth Rate is ranked higher than
82% of the 1502 Companies
in the Global Health Information Services industry.

( Industry Median: 5.40 vs. CERN: 19.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CERN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 5.8  Med: 16.7 Max: 29.6
Current: 19.1
5.8
29.6
3-Year EBITDA Growth Rate 20.30
CERN's 3-Year EBITDA Growth Rate is ranked higher than
71% of the 1264 Companies
in the Global Health Information Services industry.

( Industry Median: 7.60 vs. CERN: 20.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CERN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -11.9  Med: 16.6 Max: 74.1
Current: 20.3
-11.9
74.1
3-Year EPS without NRI Growth Rate 17.90
CERN's 3-Year EPS without NRI Growth Rate is ranked higher than
66% of the 1171 Companies
in the Global Health Information Services industry.

( Industry Median: 7.00 vs. CERN: 17.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CERN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -68.2  Med: 19.5 Max: 448.5
Current: 17.9
-68.2
448.5
GuruFocus has detected 4 Warning Signs with Cerner Corp $CERN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CERN's 30-Y Financials

Financials (Next Earnings Date: 2017-07-27 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

CERN Guru Trades in Q2 2016

George Soros 10,800 sh (New)
Joel Greenblatt 19,163 sh (New)
Manning & Napier Advisors, Inc 8,496,202 sh (+22.51%)
Vanguard Health Care Fund 16,949,730 sh (unchged)
PRIMECAP Management 20,000 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
Frank Sands 11,518,519 sh (-5.72%)
Murray Stahl 9,479 sh (-15.12%)
Paul Tudor Jones 21,608 sh (-19.61%)
Ray Dalio 54,000 sh (-35.20%)
» More
Q3 2016

CERN Guru Trades in Q3 2016

Jeremy Grantham 1,285,818 sh (New)
Jim Simons 748,404 sh (New)
Paul Tudor Jones 31,283 sh (+44.78%)
PRIMECAP Management 20,000 sh (unchged)
George Soros Sold Out
Vanguard Health Care Fund 16,772,630 sh (-1.04%)
Manning & Napier Advisors, Inc 8,197,607 sh (-3.51%)
Frank Sands 10,775,077 sh (-6.45%)
Murray Stahl 8,177 sh (-13.74%)
Ray Dalio 31,900 sh (-40.93%)
Joel Greenblatt 10,926 sh (-42.98%)
» More
Q4 2016

CERN Guru Trades in Q4 2016

Jeff Auxier 35,975 sh (New)
Arnold Van Den Berg 333,386 sh (New)
Third Avenue Management 408,707 sh (New)
Joel Greenblatt 166,304 sh (+1422.09%)
Ray Dalio 249,175 sh (+681.11%)
Jim Simons 1,252,504 sh (+67.36%)
Murray Stahl 10,397 sh (+27.15%)
Vanguard Health Care Fund 16,918,530 sh (+0.87%)
Jeremy Grantham 1,291,903 sh (+0.47%)
PRIMECAP Management 20,000 sh (unchged)
Manning & Napier Advisors, Inc 3,870,904 sh (-52.78%)
Paul Tudor Jones 12,246 sh (-60.85%)
Frank Sands 3,123,675 sh (-71.01%)
» More
Q1 2017

CERN Guru Trades in Q1 2017

George Soros 3,800 sh (New)
Steven Cohen 12,386 sh (New)
Martin Whitman 372,839 sh (New)
Jeff Auxier 96,255 sh (+167.56%)
Joel Greenblatt 205,141 sh (+23.35%)
Third Avenue Management 410,097 sh (+0.34%)
PRIMECAP Management 20,000 sh (unchged)
Ray Dalio Sold Out
Frank Sands Sold Out
Jim Simons Sold Out
Paul Tudor Jones Sold Out
Vanguard Health Care Fund 16,606,117 sh (-1.85%)
Arnold Van Den Berg 327,066 sh (-1.90%)
Jeremy Grantham 1,260,405 sh (-2.44%)
Murray Stahl 8,760 sh (-15.74%)
Manning & Napier Advisors, Inc 1,775,382 sh (-54.14%)
» More
» Details

Insider Trades

Latest Guru Trades with CERN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Health Information Services    NAICS: 519190    SIC: 8099
Compare:NYSE:VEEV, NAS:ATHN, NAS:MDSO, NAS:HQY, NAS:WBMD, NAS:INOV, NAS:PINC, NYSE:TDOC, NYSE:EVH, NAS:OMCL, NAS:QSII, NAS:HSTM, NAS:CPSI, NAS:NH, NAS:RCM, NAS:TRHC, OTCPK:COGZF, NAS:COOL, OTCPK:SNBP, OTCPK:CNAB » details
Traded in other countries:CERN.Austria, CRE.Germany, CERN.Switzerland, 0R00.UK,
Headquarter Location:USA
Cerner Corp is a supplier of health care information technology, and offers software, professional services, medical device integration, remote hosting and employer health and wellness services.

Cerner is a top-tier healthcare information technology supplier that helps to eliminate errors and improve efficiency within complex healthcare organizations. The company provides a wide range of software, hardware, and services to more than 9,000 facilities globally and has a footprint in roughly 30% of all U.S. hospitals.

Guru Investment Theses on Cerner Corp

Jeff Auxier Comments on Cerner - May 09, 2017

Cerner (NASDAQ:CERN) is a leading healthcare information technology company which provides critical software to help automate hospitals and other healthcare providers. The stock traded down to a multiyear low valuation at year end providing for an attractive entry point to this high-quality enterprise.



From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.

Check out Jeff Auxier latest stock trades

Third Avenue Management Comments on Cerner - Feb 01, 2017

Cerner (NASDAQ:CERN) is a leading health care information technology company. We have long admired Cerner as it is a well-financed compounder, having compounded book value at an average rate of 16% over the past 10 years. Delays in customer adoption of healthcare Information Technology (IT) systems as regulatory mandates have lengthened, exacerbated by concerns about potential changes to the ACA and the impact on healthcare IT spend, have negatively pressured Cerner's common stock price down from over $67 to our initial purchase cost of approximately $48, giving us an opportunity to acquire shares of Cerner common stock at an attractive valuation.

Healthcare IT has been in the sweet spot of spending for hospitals as regulatory reform and increasingly complex regulatory requirements have driven a greater need for IT solutions. The ACA and Health Information Technology Economic and Clinical Health Act (HITECH) were established to transition the U.S. healthcare system from fee-for-service towards value-based outcomes, i.e., incentivizing hospitals and providers for increasing quality of care and patient outcomes rather than the volume of procedures performed. As part of this initiative, electronic health records systems were required and analytics and data collection to monitor outcomes is increasing. Cerner is one of the market leaders in these systems. Similar to other IT companies, services and software for the installed base of systems generates high-margin recurring revenue. Further, many legacy systems are in need of upgrades to enable them to meet the new regulatory requirements. Given its market leading position, Cerner has been gaining share and is well-positioned to continue to take share. In addition, there has been consolidation within the industry, including some vendors discontinuing products.

While uncertainty remains regarding the ultimate resolution of the ACA, we believe the benefit of increased efficiencies that enhanced IT systems provide, along with increasing use cases, e.g., population health, will continue to bode well for Cerner's business, enabling the company to grow and compound value over the longer-term.

From Third Avenue Management (Trades, Portfolio)'s fourth calendar quarter 2016 shareholder letter.

Check out Third Avenue Management,Martin Whitman latest stock trades

Ratios

vs
industry
vs
history
PE Ratio 33.65
CERN's PE Ratio is ranked lower than
62% of the 1376 Companies
in the Global Health Information Services industry.

( Industry Median: 26.58 vs. CERN: 33.65 )
Ranked among companies with meaningful PE Ratio only.
CERN' s PE Ratio Range Over the Past 10 Years
Min: 14.92  Med: 36.3 Max: 54.94
Current: 33.65
14.92
54.94
Forward PE Ratio 26.11
CERN's Forward PE Ratio is ranked lower than
55% of the 352 Companies
in the Global Health Information Services industry.

( Industry Median: 23.70 vs. CERN: 26.11 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 33.65
CERN's PE Ratio without NRI is ranked lower than
61% of the 1275 Companies
in the Global Health Information Services industry.

( Industry Median: 26.95 vs. CERN: 33.65 )
Ranked among companies with meaningful PE Ratio without NRI only.
CERN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 14.53  Med: 36.46 Max: 54.94
Current: 33.65
14.53
54.94
Price-to-Owner-Earnings 41.93
CERN's Price-to-Owner-Earnings is ranked lower than
72% of the 764 Companies
in the Global Health Information Services industry.

( Industry Median: 25.21 vs. CERN: 41.93 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CERN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 18.58  Med: 36.5 Max: 104.7
Current: 41.93
18.58
104.7
PB Ratio 5.22
CERN's PB Ratio is ranked lower than
67% of the 2091 Companies
in the Global Health Information Services industry.

( Industry Median: 3.25 vs. CERN: 5.22 )
Ranked among companies with meaningful PB Ratio only.
CERN' s PB Ratio Range Over the Past 10 Years
Min: 2.05  Med: 4.61 Max: 6.95
Current: 5.22
2.05
6.95
PS Ratio 4.50
CERN's PS Ratio is ranked lower than
67% of the 2044 Companies
in the Global Health Information Services industry.

( Industry Median: 2.58 vs. CERN: 4.50 )
Ranked among companies with meaningful PS Ratio only.
CERN' s PS Ratio Range Over the Past 10 Years
Min: 1.67  Med: 4.45 Max: 7.51
Current: 4.5
1.67
7.51
Price-to-Free-Cash-Flow 60.53
CERN's Price-to-Free-Cash-Flow is ranked lower than
80% of the 807 Companies
in the Global Health Information Services industry.

( Industry Median: 26.24 vs. CERN: 60.53 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CERN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 21.74  Med: 48.66 Max: 1841.39
Current: 60.53
21.74
1841.39
Price-to-Operating-Cash-Flow 19.71
CERN's Price-to-Operating-Cash-Flow is ranked higher than
50% of the 1022 Companies
in the Global Health Information Services industry.

( Industry Median: 19.78 vs. CERN: 19.71 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CERN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.29  Med: 19.62 Max: 33.32
Current: 19.71
9.29
33.32
EV-to-EBIT 22.57
CERN's EV-to-EBIT is ranked lower than
57% of the 1418 Companies
in the Global Health Information Services industry.

( Industry Median: 18.68 vs. CERN: 22.57 )
Ranked among companies with meaningful EV-to-EBIT only.
CERN' s EV-to-EBIT Range Over the Past 10 Years
Min: 9  Med: 22.8 Max: 36.7
Current: 22.57
9
36.7
EV-to-EBITDA 14.60
CERN's EV-to-EBITDA is ranked higher than
53% of the 1545 Companies
in the Global Health Information Services industry.

( Industry Median: 15.09 vs. CERN: 14.60 )
Ranked among companies with meaningful EV-to-EBITDA only.
CERN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.7  Med: 14.5 Max: 25.2
Current: 14.6
5.7
25.2
PEG Ratio 2.08
CERN's PEG Ratio is ranked lower than
52% of the 583 Companies
in the Global Health Information Services industry.

( Industry Median: 1.97 vs. CERN: 2.08 )
Ranked among companies with meaningful PEG Ratio only.
CERN' s PEG Ratio Range Over the Past 10 Years
Min: 0.78  Med: 2.18 Max: 3.82
Current: 2.08
0.78
3.82
Shiller PE Ratio 57.56
CERN's Shiller PE Ratio is ranked lower than
68% of the 327 Companies
in the Global Health Information Services industry.

( Industry Median: 39.23 vs. CERN: 57.56 )
Ranked among companies with meaningful Shiller PE Ratio only.
CERN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 34.87  Med: 71.29 Max: 94.06
Current: 57.56
34.87
94.06
Current Ratio 2.19
CERN's Current Ratio is ranked higher than
57% of the 1822 Companies
in the Global Health Information Services industry.

( Industry Median: 1.94 vs. CERN: 2.19 )
Ranked among companies with meaningful Current Ratio only.
CERN' s Current Ratio Range Over the Past 10 Years
Min: 1.75  Med: 2.68 Max: 5.87
Current: 2.19
1.75
5.87
Quick Ratio 2.17
CERN's Quick Ratio is ranked higher than
59% of the 1822 Companies
in the Global Health Information Services industry.

( Industry Median: 1.83 vs. CERN: 2.17 )
Ranked among companies with meaningful Quick Ratio only.
CERN' s Quick Ratio Range Over the Past 10 Years
Min: 1.65  Med: 2.64 Max: 5.81
Current: 2.17
1.65
5.81
Days Inventory 8.44
CERN's Days Inventory is ranked higher than
65% of the 1109 Companies
in the Global Health Information Services industry.

( Industry Median: 18.22 vs. CERN: 8.44 )
Ranked among companies with meaningful Days Inventory only.
CERN' s Days Inventory Range Over the Past 10 Years
Min: 7.15  Med: 13.98 Max: 19.85
Current: 8.44
7.15
19.85
Days Sales Outstanding 71.72
CERN's Days Sales Outstanding is ranked lower than
55% of the 1537 Companies
in the Global Health Information Services industry.

( Industry Median: 67.07 vs. CERN: 71.72 )
Ranked among companies with meaningful Days Sales Outstanding only.
CERN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 66.04  Med: 80.17 Max: 102.12
Current: 71.72
66.04
102.12
Days Payable 94.15
CERN's Days Payable is ranked higher than
75% of the 1383 Companies
in the Global Health Information Services industry.

( Industry Median: 44.00 vs. CERN: 94.15 )
Ranked among companies with meaningful Days Payable only.
CERN' s Days Payable Range Over the Past 10 Years
Min: 47.89  Med: 99.82 Max: 115.48
Current: 94.15
47.89
115.48

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 1.40
CERN's 3-Year Average Share Buyback Ratio is ranked higher than
90% of the 1211 Companies
in the Global Health Information Services industry.

( Industry Median: -2.70 vs. CERN: 1.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CERN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -8.2  Med: -1.5 Max: 4.3
Current: 1.4
-8.2
4.3

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 158.41
CERN's Price-to-Net-Current-Asset-Value is ranked lower than
98% of the 1517 Companies
in the Global Health Information Services industry.

( Industry Median: 7.85 vs. CERN: 158.41 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
CERN' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 2  Med: 15.21 Max: 353.07
Current: 158.41
2
353.07
Price-to-Tangible-Book 10.88
CERN's Price-to-Tangible-Book is ranked lower than
75% of the 1806 Companies
in the Global Health Information Services industry.

( Industry Median: 4.64 vs. CERN: 10.88 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CERN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.83  Med: 5.08 Max: 14.44
Current: 10.88
0.83
14.44
Price-to-Intrinsic-Value-Projected-FCF 2.67
CERN's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
62% of the 991 Companies
in the Global Health Information Services industry.

( Industry Median: 2.08 vs. CERN: 2.67 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CERN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.47  Med: 2.9 Max: 7.23
Current: 2.67
1.47
7.23
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.29
CERN's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
63% of the 145 Companies
in the Global Health Information Services industry.

( Industry Median: 1.58 vs. CERN: 1.29 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.01
CERN's Price-to-Median-PS-Value is ranked higher than
61% of the 1942 Companies
in the Global Health Information Services industry.

( Industry Median: 1.15 vs. CERN: 1.01 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CERN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.09  Med: 0.7 Max: 1.6
Current: 1.01
0.09
1.6
Price-to-Peter-Lynch-Fair-Value 2.07
CERN's Price-to-Peter-Lynch-Fair-Value is ranked lower than
58% of the 431 Companies
in the Global Health Information Services industry.

( Industry Median: 1.66 vs. CERN: 2.07 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CERN' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.46  Med: 1.93 Max: 9.34
Current: 2.07
0.46
9.34
Price-to-Graham-Number 4.03
CERN's Price-to-Graham-Number is ranked lower than
72% of the 1110 Companies
in the Global Health Information Services industry.

( Industry Median: 2.46 vs. CERN: 4.03 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CERN' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.42  Med: 2.83 Max: 5.64
Current: 4.03
0.42
5.64
Earnings Yield (Greenblatt) % 4.43
CERN's Earnings Yield (Greenblatt) % is ranked higher than
65% of the 2270 Companies
in the Global Health Information Services industry.

( Industry Median: 2.12 vs. CERN: 4.43 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CERN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.7  Med: 4.4 Max: 11.1
Current: 4.43
2.7
11.1
Forward Rate of Return (Yacktman) % 17.74
CERN's Forward Rate of Return (Yacktman) % is ranked higher than
69% of the 791 Companies
in the Global Health Information Services industry.

( Industry Median: 10.79 vs. CERN: 17.74 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CERN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 1.5  Med: 17.2 Max: 22.6
Current: 17.74
1.5
22.6

More Statistics

Revenue (TTM) (Mil) $4,919
EPS (TTM) $ 1.93
Beta0.87
Short Percentage of Float6.48%
52-Week Range $47.01 - 67.50
Shares Outstanding (Mil)330.43

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 5,192 5,566 6,167
EPS ($) 2.50 2.75 3.10
EPS without NRI ($) 2.50 2.75 3.10
EPS Growth Rate
(Future 3Y To 5Y Estimate)
14.93%
Dividends per Share ($)
» More Articles for CERN

Headlines

Articles On GuruFocus.com
Cerner, AANAC Award Nursing Assistant of the Year Scholarship May 26 2017 
Cerner Announces Share Repurchase Program May 25 2017 
Truman Medical Centers and Cerner Launch Innovation Program to Combat High-Risk Chronic Conditions May 16 2017 
Workforce Magazine Announces Cerner as 2017 Workforce 100 Honoree May 11 2017 
Cerner Named to Forbes 2017 America’s Best Employers List May 10 2017 
Jeff Auxier Comments on Cerner May 09 2017 
Cerner, Fusionetics Collaborate to Integrate Assessment Programming With HealtheAthlete Platform May 01 2017 
Cerner, NeuroLogix Technologies to Integrate Tools to Advance Concussion Care Apr 24 2017 
Cerner Executives Earn ACHE’s Top Credential for Health Care Management Apr 11 2017 
St. Joseph’s Healthcare System Selects Cerner’s Clinical, Financial and Population Health Apr 11 2017 

More From Other Websites
Cerner, AANAC Award Nursing Assistant of the Year Scholarship May 26 2017
Cerner Announces Share Repurchase Program May 25 2017
Patterson remains absent from Cerner's annual shareholder meeting May 24 2017
Better Buy: Veeva Systems Inc. vs. Cerner Corporation May 23 2017
Truman Med, Cerner team up to help patients manage chronic disease May 17 2017
Cerner to Hold 2017 Shareholder Meeting May 24 May 17 2017
Truman Medical Centers and Cerner Launch Innovation Program to Combat High-Risk Chronic Conditions May 16 2017
Cerner: Behavioral health is a 'growth area' for industry May 15 2017
ETFs with exposure to Cerner Corp. : May 15, 2017 May 15 2017
Workforce Magazine Announces Cerner as 2017 Workforce 100 Honoree May 11 2017
Cerner Named to Forbes 2017 America’s Best Employers List May 10 2017
5 Central Florida companies land on Forbes 'America's Best Employers' list May 10 2017
Jeff Auxier Comments on Cerner May 09 2017
Cerner Rises On Accelerating Growth; Earns IBD Rating Upgrade May 03 2017
Cerner Corp. :CERN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 May 01 2017
Cerner, Fusionetics Collaborate to Integrate Assessment Programming With HealtheAthlete Platform May 01 2017
Edited Transcript of CERN earnings conference call or presentation 27-Apr-17 8:30pm GMT May 01 2017
The Hot Stock: Cerner Jumps 7.8%. Wait? What is Cerner?!?! Apr 28 2017
Why Royal Caribbean Cruises, Cerner, and Align Technology Jumped Today Apr 28 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)